Literature DB >> 16341152

Current practice of diagnosis and reporting of prostatic intraepithelial neoplasia and glandular atypia among genitourinary pathologists.

Lars Egevad1, William C Allsbrook, Jonathan I Epstein.   

Abstract

The criteria for diagnosing prostatic intraepithelial neoplasia (PIN) and lesions suspicious for cancer are described in the literature. However, it is unknown how these are applied in practice by experts in genitourinary (GU) pathology. A questionnaire was sent to 93 GU pathologists in countries around the world with the purpose of surveying current practices. The response rate was 69% including 40 North American pathologists and 24 from other continents. For preneoplastic lesions, the term PIN was universally endorsed by the respondents. PIN was graded by 83%, usually as low/high-grade PIN (LGPIN/HGPIN) or as HGPIN only. Most respondents would usually not report lesions that may qualify for LGPIN. A majority (81%) did not specify architectural patterns of PIN. With both HGPIN and invasive cancer present, 69% would still mention HGPIN. Among the diagnostic criteria for HGPIN were any nucleoli visible (52%), or nucleoli seen in at least 10% of cells (33%). However, 56% would diagnose HGPIN in the absence of prominent nucleoli, most commonly based on prominent pleomorphism, marked hyperchromasia or mitotic figures. The number of cores involved with HGPIN was specified by 50%. Lesions suspicious for but not diagnostic of carcinoma were reported by 45% as atypia, atypical glands or suspicious for cancer and by 42% as atypical small acinar proliferation. The degree of suspicion was further defined by 41%. Our survey data may serve as a guideline to general pathologists on how to diagnose and report atypia and PIN in prostate biopsies.

Entities:  

Mesh:

Year:  2006        PMID: 16341152     DOI: 10.1038/modpathol.3800522

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  7 in total

1.  Immunohistochemical application of D2-40 as basal cell marker in evaluating atypical small acinar proliferation of initial routine prostatic needle biopsy materials.

Authors:  Naoto Kuroda; Kazunobu Katto; Masato Tamura; Tomoyuki Shiotsu; Shoichiro Nakamura; Yuji Ohtsuki; Ondrej Hes; Michal Michal; Kaori Inoue; Masahiko Ohara; Keiko Mizuno; Gang-Hong Lee
Journal:  Med Mol Morphol       Date:  2010-09-21       Impact factor: 2.309

2.  Predicting prostate biopsy outcome: artificial neural networks and polychotomous regression are equivalent models.

Authors:  Nathan Lawrentschuk; Gina Lockwood; Peter Davies; Andy Evans; Joan Sweet; Ants Toi; Neil E Fleshner
Journal:  Int Urol Nephrol       Date:  2010-05-13       Impact factor: 2.370

Review 3.  My approach to intraductal lesions of the prostate gland.

Authors:  M Pickup; T H Van der Kwast
Journal:  J Clin Pathol       Date:  2007-01-19       Impact factor: 3.411

4.  Prostate gland biopsies and prostatectomies: an Ontario community hospital experience.

Authors:  Ken J Newell; John F Amrhein; Rashmikant J Desai; Paul F Middlebrook; Todd M Webster; Barry W Sawka; Brian F Rudrick
Journal:  Can Urol Assoc J       Date:  2008-10       Impact factor: 1.862

5.  MYC overexpression induces prostatic intraepithelial neoplasia and loss of Nkx3.1 in mouse luminal epithelial cells.

Authors:  Tsuyoshi Iwata; Denise Schultz; Jessica Hicks; Gretchen K Hubbard; Laura N Mutton; Tamara L Lotan; Carlise Bethel; Matthew T Lotz; Srinivasan Yegnasubramanian; William G Nelson; Chi V Dang; MengMeng Xu; Uzoma Anele; Cheryl M Koh; Charles J Bieberich; Angelo M De Marzo
Journal:  PLoS One       Date:  2010-02-25       Impact factor: 3.240

6.  p40 as a Basal Cell Marker in the Diagnosis of Prostate Glandular Proliferations: A Comparative Immunohistochemical Study with 34betaE12.

Authors:  Hermann Brustmann
Journal:  Patholog Res Int       Date:  2015-03-08

7.  Interobserver Variability in the Diagnosis of High-Grade Prostatic Intraepithelial Neoplasia in a Tertiary Hospital in Northern Jordan.

Authors:  Najla Aldaoud; Amer Hallak; Nour Abdo; Samir Al Bashir; Noor Marji; Ashley Graboski-Bauer
Journal:  Clin Pathol       Date:  2020-01-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.